The newborn outcomes (NBO) solution is a web-based system for referring newborn babies who screen positive for sickle cell disease (SCD) and thalassaemia.
Emma is a registered midwife who began her career in screening in 2009 as a trust antenatal and newborn screening coordinator. She is currently working as a clinical project lead for the NHS Sickle Cell and Thalassaemia Screening Programme, on secondment from her role as a senior quality assurance advisor in the south east of England. In 2018, Emma completed an MSc in Public Health and Management at the University of Brighton.
The newborn outcomes solution IT system is now live in all newborn blood spot laboratories.
Related content and links
The PHE Screening team
Public Health England (PHE) provides support and advice to the NHS-led national screening programmes. These programmes identify apparently healthy people who may be at increased risk of a disease or condition, enabling earlier treatment and informed decisions. PHE also hosts the UK National Screening Committee (UK NSC) secretariat and supports the work of the committee.
Find out more about PHE Screening and this blog.
Watch our 44 second video for an overview of how the blog works.
Comments and moderation
- NHS diabetic eye screening services and the National Diabetes Audit join forces to evaluate diabetes care 16 September 2021
- Report published marking 25 years of UK National Screening Committee 15 September 2021
- Valuable feedback from newborn blood spot failsafe solution (NBSFS) survey 14 September 2021